Summary

The global Third-party Pharmaceutical B2B Platform market size is predicted to grow from US$ 31090 million in 2025 to US$ 108267 million in 2032; it is expected to grow at a CAGR of 19.5% from 2026 to 2032.
Third-party pharmaceutical B2B platform refers to an online trading platform operated by a third-party organization independent of pharmaceutical manufacturers and buyers, serving B2B participants in the pharmaceutical industry including pharmaceutical companies, wholesale distributors, retail pharmacies, and primary healthcare institutions. These platforms provide digital services for publishing pharmaceutical product information, order matching, online transactions, payment settlement, and supporting logistics information services for medicines, medical devices, health products, and other pharmaceutical-related products. The core characteristic of a third-party platform is its intermediary role—it does not directly participate in the purchase or sale of pharmaceuticals (i.e., does not take title to goods), but rather facilitates transactions between upstream and downstream participants and generates revenue through value-added services such as transaction commissions, membership fees, data services, and supply chain financing. This distinguishes third-party platforms from internal procurement systems built by pharmaceutical manufacturers or distributors. Major global platforms include OpenFDA Data Platform, EPharmConnect, Labviva in the United States, Pharmaoffer in Europe, and YSB, Yaojingcai, Jointown in China. Service coverage spans all pharmaceutical product categories including chemical drugs, traditional Chinese medicine, biologics, medical devices, health products, and herbal ingredients. Based on operating models, platforms can be categorized into pure matching platforms, hybrid platforms (matching + self-operated), and supply chain collaboration platforms.
Volume: platforms globally processed approximately USD 450-500 billion in GMV, with China accounting for about 40% (YSB GMV reached RMB 42.0 billion in 2024; Jointown, Yaojingcai, 1 Pharmacy aggregated over RMB 150 billion), North America ~30% (Cencora Marketplace, Labviva, Truepill), Europe and Middle East ~15%, India and Southeast Asia ~10%, Latin America and Africa ~5%. Price tiers by revenue model: transaction commissions dominate at 1.5-3% of GMV (2-3% typical in China, 1.5-2% in North America); annual membership fees USD 20,000-50,000 per enterprise (RMB 200,000-500,000 in China); data service reports RMB 50,000-200,000 (China) or USD 10,000-50,000 (North America); API access fees USD 10,000-100,000 annually; supply chain financing interest rates 8-15% APR (depending on credit rating). Gross margins by segment: pure matching platforms 60-80% (asset-light, no inventory risk, e.g., YSB, Yaozs); hybrid platforms (matching + self-operated) 25-40% (including inventory and fulfillment costs); API-first platforms 70-85% (technology-driven, low marginal cost); supply chain collaboration platforms 30-50% (including logistics and financing). Downstream primary applications: retail pharmacies (55-60% of platform volume, especially independent and small chain pharmacies), hospitals & clinics (15-20%, focused on compliant bulk procurement), pharmaceutical manufacturers (10-15%, purchasing APIs or selling finished products), wholesalers & distributors (5-10%, migrating B2B trading to platforms), primary care & community clinics (5-10%, in underserved areas). Growth applications: API-first procurement embedding (25-30% CAGR, large pharmacy chains and hospital groups integrating platforms via APIs) and cross-border pharmaceutical B2B trading (20-25% CAGR, platforms like Drugdu and Pharmaoffer facilitating international API and finished drug matching). Upstream: pharmaceutical and medical device manufacturers (global pharmaceutical market ~USD 1.6 trillion; global API market ~USD 220 billion). Midstream: third-party pharmaceutical B2B platforms including China market leaders (YSB, Jointown, Yaojingcai, 1 Pharmacy, Goldleta, Yaozs, Yaozhi, Global Pharmaceutical, Yajuduo), North America market leaders (Cencora Marketplace, Labviva, Truepill, TraceLink, GraphiteRx), European platforms (Pharmaoffer, AEP, Validaide, Zentiva), India and Southeast Asia platforms (PharmaHopers, MedPro, PharmaSource D2R, Dawaai), Latin America and Middle East platforms (ConectNext, Yaydoo, MercadoLibre, Axmed), and cross-border platforms (Drugdu, Pharmint). Downstream: global pharmacies, hospitals, clinics, pharma companies, and wholesalers. Industry structure: highly regionalized, concentrated in China, technology-driven in North America, rapid rise in emerging markets. China market features a multi-strong landscape with YSB holding 15-20% market share; North America led by Cencora Marketplace (parent company annual revenue >USD 265 billion) with technology platforms like Labviva and Truepill dominating AI procurement and digital pharmacy; Europe characterized by cross-border API matching; India fragmented and undergoing consolidation; Latin America and Middle East seeing high growth (30%+ CAGR). Uncertainties include varying pharmaceutical regulations (online prescription trading permissions, e-prescription interoperability), coopetition with distributors and manufacturers (some large pharma companies building in-house platforms), data security and privacy regulations, and cross-border e-commerce tariffs and compliance barriers. Conclusion: the third-party pharmaceutical B2B platform industry is in a growth-to-maturity transition phase (15-20% annual growth), driven by cost reduction and efficiency gains from pharmaceutical supply chain digitalization and unmet procurement needs of small-format buyers. Structural characteristic: China market mature and concentrated, North America technology-driven with room for penetration, emerging markets rapidly filling traditional distribution gaps, making it a core infrastructure of pharmaceutical distribution digital transformation.
LPI (LP Information)' newest research report, the “Third-party Pharmaceutical B2B Platform Industry Forecast” looks at past sales and reviews total world Third-party Pharmaceutical B2B Platform sales in 2025, providing a comprehensive analysis by region and market sector of projected Third-party Pharmaceutical B2B Platform sales for 2026 through 2032. With Third-party Pharmaceutical B2B Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Third-party Pharmaceutical B2B Platform industry.
This Insight Report provides a comprehensive analysis of the global Third-party Pharmaceutical B2B Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Third-party Pharmaceutical B2B Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Third-party Pharmaceutical B2B Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Third-party Pharmaceutical B2B Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Third-party Pharmaceutical B2B Platform.
This report presents a comprehensive overview, market shares, and growth opportunities of Third-party Pharmaceutical B2B Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pure matching platform
Hybrid platform (matching + self-operated)
Supply chain collaboration platform
API-first platform
Segmentation by Product Category:
Full-category pharmaceutical platform (approx. 55-60%)
API & bulk drug platform (approx. 15-20%)
Medical device & equipment platform (approx. 10-15%)
Chinese traditional medicine platform (approx. 8-12%)
Healthcare & wellness platform (approx. 5-8%)
Segmentation by Module:
Online ordering & inventory management
Regulatory compliance & licensing
Cold chain validation
Sample & promotional product management
Price comparison & dynamic pricing
Others
Segmentation by Core Revenue:
Commission-based
Subscription/membership
Service fee (SaaS/data)
Hybrid
Segmentation by Application:
Retail pharmacies
Hospitals & clinics
Pharmaceutical manufacturers
Wholesalers & distributors
Primary care & community clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
YSB (CN)
Jointown (CN)
Yaojingcai (CN)
1 Pharmacy (CN)
Goldleta Pharmaceutical Trading Network (CN)
Yaozs (CN)
Yaozhi (CN)
Global Pharmaceutical (CN)
Yaomed (CN)
Yajuduo (CN)
Drugdu (CN)
Labviva (US)
Cencora Marketplace (US)
Truepill (US)
TraceLink (US)
GraphiteRx (US)
MedWell Ai (US)
BoomRx (US)
Pharma Inquiry (US)
Pharmaoffer (NL)
AEP (DE)
Validaide (NL)
Sanicare (DE)
Zentiva (Zent2U) (CZ)
DawaDose (SA)
Dawaai (PK)
PharmaHopers (IN)
MedPro (IN)
PharmaSource D2R (IN)
Biddano (IN)
Pharmint (IN)
HealthCRAD Wholesale (IN)
TradeIndia (IN)
ChemDmart (IN)
ConectNext (MX)
Yaydoo (MX)
MercadoLibre (B2B Pharma) (AR)
Yeatrade (CO)
Axmed (CH)

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Third-party Pharmaceutical B2B Platform Market Size (2021-2032)
2.1.2 Third-party Pharmaceutical B2B Platform Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Third-party Pharmaceutical B2B Platform by Country/Region (2021, 2025 & 2032)
2.2 Third-party Pharmaceutical B2B Platform Segment by Type
2.2.1 Pure matching platform
2.2.2 Hybrid platform (matching + self-operated)
2.2.3 Supply chain collaboration platform
2.2.4 API-first platform
2.2.5 Third-party Pharmaceutical B2B Platform Market Size by Type
2.2.5.1 Third-party Pharmaceutical B2B Platform Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Type (2021-2026)
2.3 Third-party Pharmaceutical B2B Platform Segment by Product Category
2.3.1 Full-category pharmaceutical platform (approx. 55-60%)
2.3.2 API & bulk drug platform (approx. 15-20%)
2.3.3 Medical device & equipment platform (approx. 10-15%)
2.3.4 Chinese traditional medicine platform (approx. 8-12%)
2.3.5 Healthcare & wellness platform (approx. 5-8%)
2.3.6 Third-party Pharmaceutical B2B Platform Market Size by Product Category
2.3.6.1 Third-party Pharmaceutical B2B Platform Market Size CAGR by Product Category (2021 VS 2025 VS 2032)
2.3.6.2 Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Product Category (2021-2026)
2.4 Third-party Pharmaceutical B2B Platform Segment by Module
2.4.1 Online ordering & inventory management
2.4.2 Regulatory compliance & licensing
2.4.3 Cold chain validation
2.4.4 Sample & promotional product management
2.4.5 Price comparison & dynamic pricing
2.4.6 Others
2.4.7 Third-party Pharmaceutical B2B Platform Market Size by Module
2.4.7.1 Third-party Pharmaceutical B2B Platform Market Size CAGR by Module (2021 VS 2025 VS 2032)
2.4.7.2 Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Module (2021-2026)
2.5 Third-party Pharmaceutical B2B Platform Segment by Core Revenue
2.5.1 Commission-based
2.5.2 Subscription/membership
2.5.3 Service fee (SaaS/data)
2.5.4 Hybrid
2.5.5 Third-party Pharmaceutical B2B Platform Market Size by Core Revenue
2.5.5.1 Third-party Pharmaceutical B2B Platform Market Size CAGR by Core Revenue (2021 VS 2025 VS 2032)
2.5.5.2 Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Core Revenue (2021-2026)
2.6 Third-party Pharmaceutical B2B Platform Segment by Application
2.6.1 Retail pharmacies
2.6.2 Hospitals & clinics
2.6.3 Pharmaceutical manufacturers
2.6.4 Wholesalers & distributors
2.6.5 Primary care & community clinics
2.6.6 Others
2.6.7 Third-party Pharmaceutical B2B Platform Market Size by Application
2.6.7.1 Third-party Pharmaceutical B2B Platform Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.6.7.2 Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Application (2021-2026)
3 Third-party Pharmaceutical B2B Platform Market Size by Player
3.1 Third-party Pharmaceutical B2B Platform Market Size Market Share by Player
3.1.1 Global Third-party Pharmaceutical B2B Platform Revenue by Player (2021-2026)
3.1.2 Global Third-party Pharmaceutical B2B Platform Revenue Market Share by Player (2021-2026)
3.2 Global Third-party Pharmaceutical B2B Platform Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Third-party Pharmaceutical B2B Platform by Region
4.1 Third-party Pharmaceutical B2B Platform Market Size by Region (2021-2026)
4.2 Global Third-party Pharmaceutical B2B Platform Annual Revenue by Country/Region (2021-2026)
4.3 Americas Third-party Pharmaceutical B2B Platform Market Size Growth (2021-2026)
4.4 APAC Third-party Pharmaceutical B2B Platform Market Size Growth (2021-2026)
4.5 Europe Third-party Pharmaceutical B2B Platform Market Size Growth (2021-2026)
4.6 Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size Growth (2021-2026)
5 Americas
5.1 Americas Third-party Pharmaceutical B2B Platform Market Size by Country (2021-2026)
5.2 Americas Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026)
5.3 Americas Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Third-party Pharmaceutical B2B Platform Market Size by Region (2021-2026)
6.2 APAC Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026)
6.3 APAC Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Third-party Pharmaceutical B2B Platform Market Size by Country (2021-2026)
7.2 Europe Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026)
7.3 Europe Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Third-party Pharmaceutical B2B Platform by Region (2021-2026)
8.2 Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026)
8.3 Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Third-party Pharmaceutical B2B Platform Market Forecast
10.1 Global Third-party Pharmaceutical B2B Platform Forecast by Region (2027-2032)
10.1.1 Global Third-party Pharmaceutical B2B Platform Forecast by Region (2027-2032)
10.1.2 Americas Third-party Pharmaceutical B2B Platform Forecast
10.1.3 APAC Third-party Pharmaceutical B2B Platform Forecast
10.1.4 Europe Third-party Pharmaceutical B2B Platform Forecast
10.1.5 Middle East & Africa Third-party Pharmaceutical B2B Platform Forecast
10.2 Americas Third-party Pharmaceutical B2B Platform Forecast by Country (2027-2032)
10.2.1 United States Market Third-party Pharmaceutical B2B Platform Forecast
10.2.2 Canada Market Third-party Pharmaceutical B2B Platform Forecast
10.2.3 Mexico Market Third-party Pharmaceutical B2B Platform Forecast
10.2.4 Brazil Market Third-party Pharmaceutical B2B Platform Forecast
10.3 APAC Third-party Pharmaceutical B2B Platform Forecast by Region (2027-2032)
10.3.1 China Third-party Pharmaceutical B2B Platform Market Forecast
10.3.2 Japan Market Third-party Pharmaceutical B2B Platform Forecast
10.3.3 Korea Market Third-party Pharmaceutical B2B Platform Forecast
10.3.4 Southeast Asia Market Third-party Pharmaceutical B2B Platform Forecast
10.3.5 India Market Third-party Pharmaceutical B2B Platform Forecast
10.3.6 Australia Market Third-party Pharmaceutical B2B Platform Forecast
10.4 Europe Third-party Pharmaceutical B2B Platform Forecast by Country (2027-2032)
10.4.1 Germany Market Third-party Pharmaceutical B2B Platform Forecast
10.4.2 France Market Third-party Pharmaceutical B2B Platform Forecast
10.4.3 UK Market Third-party Pharmaceutical B2B Platform Forecast
10.4.4 Italy Market Third-party Pharmaceutical B2B Platform Forecast
10.4.5 Russia Market Third-party Pharmaceutical B2B Platform Forecast
10.5 Middle East & Africa Third-party Pharmaceutical B2B Platform Forecast by Region (2027-2032)
10.5.1 Egypt Market Third-party Pharmaceutical B2B Platform Forecast
10.5.2 South Africa Market Third-party Pharmaceutical B2B Platform Forecast
10.5.3 Israel Market Third-party Pharmaceutical B2B Platform Forecast
10.5.4 Turkey Market Third-party Pharmaceutical B2B Platform Forecast
10.6 Global Third-party Pharmaceutical B2B Platform Forecast by Type (2027-2032)
10.7 Global Third-party Pharmaceutical B2B Platform Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Third-party Pharmaceutical B2B Platform Forecast
11 Key Players Analysis
11.1 YSB (CN)
11.1.1 YSB (CN) Company Information
11.1.2 YSB (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.1.3 YSB (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 YSB (CN) Main Business Overview
11.1.5 YSB (CN) Latest Developments
11.2 Jointown (CN)
11.2.1 Jointown (CN) Company Information
11.2.2 Jointown (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.2.3 Jointown (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Jointown (CN) Main Business Overview
11.2.5 Jointown (CN) Latest Developments
11.3 Yaojingcai (CN)
11.3.1 Yaojingcai (CN) Company Information
11.3.2 Yaojingcai (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.3.3 Yaojingcai (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Yaojingcai (CN) Main Business Overview
11.3.5 Yaojingcai (CN) Latest Developments
11.4 1 Pharmacy (CN)
11.4.1 1 Pharmacy (CN) Company Information
11.4.2 1 Pharmacy (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.4.3 1 Pharmacy (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 1 Pharmacy (CN) Main Business Overview
11.4.5 1 Pharmacy (CN) Latest Developments
11.5 Goldleta Pharmaceutical Trading Network (CN)
11.5.1 Goldleta Pharmaceutical Trading Network (CN) Company Information
11.5.2 Goldleta Pharmaceutical Trading Network (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.5.3 Goldleta Pharmaceutical Trading Network (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Goldleta Pharmaceutical Trading Network (CN) Main Business Overview
11.5.5 Goldleta Pharmaceutical Trading Network (CN) Latest Developments
11.6 Yaozs (CN)
11.6.1 Yaozs (CN) Company Information
11.6.2 Yaozs (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.6.3 Yaozs (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Yaozs (CN) Main Business Overview
11.6.5 Yaozs (CN) Latest Developments
11.7 Yaozhi (CN)
11.7.1 Yaozhi (CN) Company Information
11.7.2 Yaozhi (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.7.3 Yaozhi (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Yaozhi (CN) Main Business Overview
11.7.5 Yaozhi (CN) Latest Developments
11.8 Global Pharmaceutical (CN)
11.8.1 Global Pharmaceutical (CN) Company Information
11.8.2 Global Pharmaceutical (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.8.3 Global Pharmaceutical (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Global Pharmaceutical (CN) Main Business Overview
11.8.5 Global Pharmaceutical (CN) Latest Developments
11.9 Yaomed (CN)
11.9.1 Yaomed (CN) Company Information
11.9.2 Yaomed (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.9.3 Yaomed (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Yaomed (CN) Main Business Overview
11.9.5 Yaomed (CN) Latest Developments
11.10 Yajuduo (CN)
11.10.1 Yajuduo (CN) Company Information
11.10.2 Yajuduo (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.10.3 Yajuduo (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Yajuduo (CN) Main Business Overview
11.10.5 Yajuduo (CN) Latest Developments
11.11 Drugdu (CN)
11.11.1 Drugdu (CN) Company Information
11.11.2 Drugdu (CN) Third-party Pharmaceutical B2B Platform Product Offered
11.11.3 Drugdu (CN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Drugdu (CN) Main Business Overview
11.11.5 Drugdu (CN) Latest Developments
11.12 Labviva (US)
11.12.1 Labviva (US) Company Information
11.12.2 Labviva (US) Third-party Pharmaceutical B2B Platform Product Offered
11.12.3 Labviva (US) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Labviva (US) Main Business Overview
11.12.5 Labviva (US) Latest Developments
11.13 Cencora Marketplace (US)
11.13.1 Cencora Marketplace (US) Company Information
11.13.2 Cencora Marketplace (US) Third-party Pharmaceutical B2B Platform Product Offered
11.13.3 Cencora Marketplace (US) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Cencora Marketplace (US) Main Business Overview
11.13.5 Cencora Marketplace (US) Latest Developments
11.14 Truepill (US)
11.14.1 Truepill (US) Company Information
11.14.2 Truepill (US) Third-party Pharmaceutical B2B Platform Product Offered
11.14.3 Truepill (US) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Truepill (US) Main Business Overview
11.14.5 Truepill (US) Latest Developments
11.15 TraceLink (US)
11.15.1 TraceLink (US) Company Information
11.15.2 TraceLink (US) Third-party Pharmaceutical B2B Platform Product Offered
11.15.3 TraceLink (US) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 TraceLink (US) Main Business Overview
11.15.5 TraceLink (US) Latest Developments
11.16 GraphiteRx (US)
11.16.1 GraphiteRx (US) Company Information
11.16.2 GraphiteRx (US) Third-party Pharmaceutical B2B Platform Product Offered
11.16.3 GraphiteRx (US) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 GraphiteRx (US) Main Business Overview
11.16.5 GraphiteRx (US) Latest Developments
11.17 MedWell Ai (US)
11.17.1 MedWell Ai (US) Company Information
11.17.2 MedWell Ai (US) Third-party Pharmaceutical B2B Platform Product Offered
11.17.3 MedWell Ai (US) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 MedWell Ai (US) Main Business Overview
11.17.5 MedWell Ai (US) Latest Developments
11.18 BoomRx (US)
11.18.1 BoomRx (US) Company Information
11.18.2 BoomRx (US) Third-party Pharmaceutical B2B Platform Product Offered
11.18.3 BoomRx (US) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 BoomRx (US) Main Business Overview
11.18.5 BoomRx (US) Latest Developments
11.19 Pharma Inquiry (US)
11.19.1 Pharma Inquiry (US) Company Information
11.19.2 Pharma Inquiry (US) Third-party Pharmaceutical B2B Platform Product Offered
11.19.3 Pharma Inquiry (US) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Pharma Inquiry (US) Main Business Overview
11.19.5 Pharma Inquiry (US) Latest Developments
11.20 Pharmaoffer (NL)
11.20.1 Pharmaoffer (NL) Company Information
11.20.2 Pharmaoffer (NL) Third-party Pharmaceutical B2B Platform Product Offered
11.20.3 Pharmaoffer (NL) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Pharmaoffer (NL) Main Business Overview
11.20.5 Pharmaoffer (NL) Latest Developments
11.21 AEP (DE)
11.21.1 AEP (DE) Company Information
11.21.2 AEP (DE) Third-party Pharmaceutical B2B Platform Product Offered
11.21.3 AEP (DE) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 AEP (DE) Main Business Overview
11.21.5 AEP (DE) Latest Developments
11.22 Validaide (NL)
11.22.1 Validaide (NL) Company Information
11.22.2 Validaide (NL) Third-party Pharmaceutical B2B Platform Product Offered
11.22.3 Validaide (NL) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Validaide (NL) Main Business Overview
11.22.5 Validaide (NL) Latest Developments
11.23 Sanicare (DE)
11.23.1 Sanicare (DE) Company Information
11.23.2 Sanicare (DE) Third-party Pharmaceutical B2B Platform Product Offered
11.23.3 Sanicare (DE) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Sanicare (DE) Main Business Overview
11.23.5 Sanicare (DE) Latest Developments
11.24 Zentiva (Zent2U) (CZ)
11.24.1 Zentiva (Zent2U) (CZ) Company Information
11.24.2 Zentiva (Zent2U) (CZ) Third-party Pharmaceutical B2B Platform Product Offered
11.24.3 Zentiva (Zent2U) (CZ) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Zentiva (Zent2U) (CZ) Main Business Overview
11.24.5 Zentiva (Zent2U) (CZ) Latest Developments
11.25 DawaDose (SA)
11.25.1 DawaDose (SA) Company Information
11.25.2 DawaDose (SA) Third-party Pharmaceutical B2B Platform Product Offered
11.25.3 DawaDose (SA) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 DawaDose (SA) Main Business Overview
11.25.5 DawaDose (SA) Latest Developments
11.26 Dawaai (PK)
11.26.1 Dawaai (PK) Company Information
11.26.2 Dawaai (PK) Third-party Pharmaceutical B2B Platform Product Offered
11.26.3 Dawaai (PK) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 Dawaai (PK) Main Business Overview
11.26.5 Dawaai (PK) Latest Developments
11.27 PharmaHopers (IN)
11.27.1 PharmaHopers (IN) Company Information
11.27.2 PharmaHopers (IN) Third-party Pharmaceutical B2B Platform Product Offered
11.27.3 PharmaHopers (IN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.27.4 PharmaHopers (IN) Main Business Overview
11.27.5 PharmaHopers (IN) Latest Developments
11.28 MedPro (IN)
11.28.1 MedPro (IN) Company Information
11.28.2 MedPro (IN) Third-party Pharmaceutical B2B Platform Product Offered
11.28.3 MedPro (IN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.28.4 MedPro (IN) Main Business Overview
11.28.5 MedPro (IN) Latest Developments
11.29 PharmaSource D2R (IN)
11.29.1 PharmaSource D2R (IN) Company Information
11.29.2 PharmaSource D2R (IN) Third-party Pharmaceutical B2B Platform Product Offered
11.29.3 PharmaSource D2R (IN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.29.4 PharmaSource D2R (IN) Main Business Overview
11.29.5 PharmaSource D2R (IN) Latest Developments
11.30 Biddano (IN)
11.30.1 Biddano (IN) Company Information
11.30.2 Biddano (IN) Third-party Pharmaceutical B2B Platform Product Offered
11.30.3 Biddano (IN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.30.4 Biddano (IN) Main Business Overview
11.30.5 Biddano (IN) Latest Developments
11.31 Pharmint (IN)
11.31.1 Pharmint (IN) Company Information
11.31.2 Pharmint (IN) Third-party Pharmaceutical B2B Platform Product Offered
11.31.3 Pharmint (IN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.31.4 Pharmint (IN) Main Business Overview
11.31.5 Pharmint (IN) Latest Developments
11.32 HealthCRAD Wholesale (IN)
11.32.1 HealthCRAD Wholesale (IN) Company Information
11.32.2 HealthCRAD Wholesale (IN) Third-party Pharmaceutical B2B Platform Product Offered
11.32.3 HealthCRAD Wholesale (IN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.32.4 HealthCRAD Wholesale (IN) Main Business Overview
11.32.5 HealthCRAD Wholesale (IN) Latest Developments
11.33 TradeIndia (IN)
11.33.1 TradeIndia (IN) Company Information
11.33.2 TradeIndia (IN) Third-party Pharmaceutical B2B Platform Product Offered
11.33.3 TradeIndia (IN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.33.4 TradeIndia (IN) Main Business Overview
11.33.5 TradeIndia (IN) Latest Developments
11.34 ChemDmart (IN)
11.34.1 ChemDmart (IN) Company Information
11.34.2 ChemDmart (IN) Third-party Pharmaceutical B2B Platform Product Offered
11.34.3 ChemDmart (IN) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.34.4 ChemDmart (IN) Main Business Overview
11.34.5 ChemDmart (IN) Latest Developments
11.35 ConectNext (MX)
11.35.1 ConectNext (MX) Company Information
11.35.2 ConectNext (MX) Third-party Pharmaceutical B2B Platform Product Offered
11.35.3 ConectNext (MX) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.35.4 ConectNext (MX) Main Business Overview
11.35.5 ConectNext (MX) Latest Developments
11.36 Yaydoo (MX)
11.36.1 Yaydoo (MX) Company Information
11.36.2 Yaydoo (MX) Third-party Pharmaceutical B2B Platform Product Offered
11.36.3 Yaydoo (MX) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.36.4 Yaydoo (MX) Main Business Overview
11.36.5 Yaydoo (MX) Latest Developments
11.37 MercadoLibre (B2B Pharma) (AR)
11.37.1 MercadoLibre (B2B Pharma) (AR) Company Information
11.37.2 MercadoLibre (B2B Pharma) (AR) Third-party Pharmaceutical B2B Platform Product Offered
11.37.3 MercadoLibre (B2B Pharma) (AR) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.37.4 MercadoLibre (B2B Pharma) (AR) Main Business Overview
11.37.5 MercadoLibre (B2B Pharma) (AR) Latest Developments
11.38 Yeatrade (CO)
11.38.1 Yeatrade (CO) Company Information
11.38.2 Yeatrade (CO) Third-party Pharmaceutical B2B Platform Product Offered
11.38.3 Yeatrade (CO) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.38.4 Yeatrade (CO) Main Business Overview
11.38.5 Yeatrade (CO) Latest Developments
11.39 Axmed (CH)
11.39.1 Axmed (CH) Company Information
11.39.2 Axmed (CH) Third-party Pharmaceutical B2B Platform Product Offered
11.39.3 Axmed (CH) Third-party Pharmaceutical B2B Platform Revenue, Gross Margin and Market Share (2021-2026)
11.39.4 Axmed (CH) Main Business Overview
11.39.5 Axmed (CH) Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Third-party Pharmaceutical B2B Platform Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Third-party Pharmaceutical B2B Platform Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Pure matching platform
Table 4. Major Players of Hybrid platform (matching + self-operated)
Table 5. Major Players of Supply chain collaboration platform
Table 6. Major Players of API-first platform
Table 7. Third-party Pharmaceutical B2B Platform Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Full-category pharmaceutical platform (approx. 55-60%)
Table 11. Major Players of API & bulk drug platform (approx. 15-20%)
Table 12. Major Players of Medical device & equipment platform (approx. 10-15%)
Table 13. Major Players of Chinese traditional medicine platform (approx. 8-12%)
Table 14. Major Players of Healthcare & wellness platform (approx. 5-8%)
Table 15. Third-party Pharmaceutical B2B Platform Market Size CAGR by Product Category (2021 VS 2025 VS 2032) & ($ millions)
Table 16. Global Third-party Pharmaceutical B2B Platform Market Size by Product Category (2021-2026) & ($ millions)
Table 17. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Product Category (2021-2026)
Table 18. Major Players of Online ordering & inventory management
Table 19. Major Players of Regulatory compliance & licensing
Table 20. Major Players of Cold chain validation
Table 21. Major Players of Sample & promotional product management
Table 22. Major Players of Price comparison & dynamic pricing
Table 23. Major Players of Others
Table 24. Third-party Pharmaceutical B2B Platform Market Size CAGR by Module (2021 VS 2025 VS 2032) & ($ millions)
Table 25. Global Third-party Pharmaceutical B2B Platform Market Size by Module (2021-2026) & ($ millions)
Table 26. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Module (2021-2026)
Table 27. Major Players of Commission-based
Table 28. Major Players of Subscription/membership
Table 29. Major Players of Service fee (SaaS/data)
Table 30. Major Players of Hybrid
Table 31. Third-party Pharmaceutical B2B Platform Market Size CAGR by Core Revenue (2021 VS 2025 VS 2032) & ($ millions)
Table 32. Global Third-party Pharmaceutical B2B Platform Market Size by Core Revenue (2021-2026) & ($ millions)
Table 33. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Core Revenue (2021-2026)
Table 34. Third-party Pharmaceutical B2B Platform Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 35. Global Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026) & ($ millions)
Table 36. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Application (2021-2026)
Table 37. Global Third-party Pharmaceutical B2B Platform Revenue by Player (2021-2026) & ($ millions)
Table 38. Global Third-party Pharmaceutical B2B Platform Revenue Market Share by Player (2021-2026)
Table 39. Third-party Pharmaceutical B2B Platform Key Players Head office and Products Offered
Table 40. Third-party Pharmaceutical B2B Platform Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Mergers & Acquisitions, Expansion
Table 43. Global Third-party Pharmaceutical B2B Platform Market Size by Region (2021-2026) & ($ millions)
Table 44. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Region (2021-2026)
Table 45. Global Third-party Pharmaceutical B2B Platform Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Third-party Pharmaceutical B2B Platform Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Third-party Pharmaceutical B2B Platform Market Size by Country (2021-2026) & ($ millions)
Table 48. Americas Third-party Pharmaceutical B2B Platform Market Size Market Share by Country (2021-2026)
Table 49. Americas Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026) & ($ millions)
Table 50. Americas Third-party Pharmaceutical B2B Platform Market Size Market Share by Type (2021-2026)
Table 51. Americas Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026) & ($ millions)
Table 52. Americas Third-party Pharmaceutical B2B Platform Market Size Market Share by Application (2021-2026)
Table 53. APAC Third-party Pharmaceutical B2B Platform Market Size by Region (2021-2026) & ($ millions)
Table 54. APAC Third-party Pharmaceutical B2B Platform Market Size Market Share by Region (2021-2026)
Table 55. APAC Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026) & ($ millions)
Table 56. APAC Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026) & ($ millions)
Table 57. Europe Third-party Pharmaceutical B2B Platform Market Size by Country (2021-2026) & ($ millions)
Table 58. Europe Third-party Pharmaceutical B2B Platform Market Size Market Share by Country (2021-2026)
Table 59. Europe Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026) & ($ millions)
Table 60. Europe Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026) & ($ millions)
Table 61. Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size by Region (2021-2026) & ($ millions)
Table 62. Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size by Type (2021-2026) & ($ millions)
Table 63. Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size by Application (2021-2026) & ($ millions)
Table 64. Key Market Drivers & Growth Opportunities of Third-party Pharmaceutical B2B Platform
Table 65. Key Market Challenges & Risks of Third-party Pharmaceutical B2B Platform
Table 66. Key Industry Trends of Third-party Pharmaceutical B2B Platform
Table 67. Global Third-party Pharmaceutical B2B Platform Market Size Forecast by Region (2027-2032) & ($ millions)
Table 68. Global Third-party Pharmaceutical B2B Platform Market Size Market Share Forecast by Region (2027-2032)
Table 69. Global Third-party Pharmaceutical B2B Platform Market Size Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Third-party Pharmaceutical B2B Platform Market Size Forecast by Application (2027-2032) & ($ millions)
Table 71. YSB (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 72. YSB (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 73. YSB (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. YSB (CN) Main Business
Table 75. YSB (CN) Latest Developments
Table 76. Jointown (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 77. Jointown (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 78. Jointown (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Jointown (CN) Main Business
Table 80. Jointown (CN) Latest Developments
Table 81. Yaojingcai (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 82. Yaojingcai (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 83. Yaojingcai (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Yaojingcai (CN) Main Business
Table 85. Yaojingcai (CN) Latest Developments
Table 86. 1 Pharmacy (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 87. 1 Pharmacy (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 88. 1 Pharmacy (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. 1 Pharmacy (CN) Main Business
Table 90. 1 Pharmacy (CN) Latest Developments
Table 91. Goldleta Pharmaceutical Trading Network (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 92. Goldleta Pharmaceutical Trading Network (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 93. Goldleta Pharmaceutical Trading Network (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Goldleta Pharmaceutical Trading Network (CN) Main Business
Table 95. Goldleta Pharmaceutical Trading Network (CN) Latest Developments
Table 96. Yaozs (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 97. Yaozs (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 98. Yaozs (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Yaozs (CN) Main Business
Table 100. Yaozs (CN) Latest Developments
Table 101. Yaozhi (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 102. Yaozhi (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 103. Yaozhi (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Yaozhi (CN) Main Business
Table 105. Yaozhi (CN) Latest Developments
Table 106. Global Pharmaceutical (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 107. Global Pharmaceutical (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 108. Global Pharmaceutical (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Global Pharmaceutical (CN) Main Business
Table 110. Global Pharmaceutical (CN) Latest Developments
Table 111. Yaomed (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 112. Yaomed (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 113. Yaomed (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Yaomed (CN) Main Business
Table 115. Yaomed (CN) Latest Developments
Table 116. Yajuduo (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 117. Yajuduo (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 118. Yajuduo (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Yajuduo (CN) Main Business
Table 120. Yajuduo (CN) Latest Developments
Table 121. Drugdu (CN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 122. Drugdu (CN) Third-party Pharmaceutical B2B Platform Product Offered
Table 123. Drugdu (CN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Drugdu (CN) Main Business
Table 125. Drugdu (CN) Latest Developments
Table 126. Labviva (US) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 127. Labviva (US) Third-party Pharmaceutical B2B Platform Product Offered
Table 128. Labviva (US) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Labviva (US) Main Business
Table 130. Labviva (US) Latest Developments
Table 131. Cencora Marketplace (US) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 132. Cencora Marketplace (US) Third-party Pharmaceutical B2B Platform Product Offered
Table 133. Cencora Marketplace (US) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Cencora Marketplace (US) Main Business
Table 135. Cencora Marketplace (US) Latest Developments
Table 136. Truepill (US) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 137. Truepill (US) Third-party Pharmaceutical B2B Platform Product Offered
Table 138. Truepill (US) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Truepill (US) Main Business
Table 140. Truepill (US) Latest Developments
Table 141. TraceLink (US) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 142. TraceLink (US) Third-party Pharmaceutical B2B Platform Product Offered
Table 143. TraceLink (US) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. TraceLink (US) Main Business
Table 145. TraceLink (US) Latest Developments
Table 146. GraphiteRx (US) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 147. GraphiteRx (US) Third-party Pharmaceutical B2B Platform Product Offered
Table 148. GraphiteRx (US) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. GraphiteRx (US) Main Business
Table 150. GraphiteRx (US) Latest Developments
Table 151. MedWell Ai (US) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 152. MedWell Ai (US) Third-party Pharmaceutical B2B Platform Product Offered
Table 153. MedWell Ai (US) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 154. MedWell Ai (US) Main Business
Table 155. MedWell Ai (US) Latest Developments
Table 156. BoomRx (US) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 157. BoomRx (US) Third-party Pharmaceutical B2B Platform Product Offered
Table 158. BoomRx (US) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 159. BoomRx (US) Main Business
Table 160. BoomRx (US) Latest Developments
Table 161. Pharma Inquiry (US) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 162. Pharma Inquiry (US) Third-party Pharmaceutical B2B Platform Product Offered
Table 163. Pharma Inquiry (US) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 164. Pharma Inquiry (US) Main Business
Table 165. Pharma Inquiry (US) Latest Developments
Table 166. Pharmaoffer (NL) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 167. Pharmaoffer (NL) Third-party Pharmaceutical B2B Platform Product Offered
Table 168. Pharmaoffer (NL) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 169. Pharmaoffer (NL) Main Business
Table 170. Pharmaoffer (NL) Latest Developments
Table 171. AEP (DE) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 172. AEP (DE) Third-party Pharmaceutical B2B Platform Product Offered
Table 173. AEP (DE) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 174. AEP (DE) Main Business
Table 175. AEP (DE) Latest Developments
Table 176. Validaide (NL) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 177. Validaide (NL) Third-party Pharmaceutical B2B Platform Product Offered
Table 178. Validaide (NL) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 179. Validaide (NL) Main Business
Table 180. Validaide (NL) Latest Developments
Table 181. Sanicare (DE) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 182. Sanicare (DE) Third-party Pharmaceutical B2B Platform Product Offered
Table 183. Sanicare (DE) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 184. Sanicare (DE) Main Business
Table 185. Sanicare (DE) Latest Developments
Table 186. Zentiva (Zent2U) (CZ) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 187. Zentiva (Zent2U) (CZ) Third-party Pharmaceutical B2B Platform Product Offered
Table 188. Zentiva (Zent2U) (CZ) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 189. Zentiva (Zent2U) (CZ) Main Business
Table 190. Zentiva (Zent2U) (CZ) Latest Developments
Table 191. DawaDose (SA) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 192. DawaDose (SA) Third-party Pharmaceutical B2B Platform Product Offered
Table 193. DawaDose (SA) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 194. DawaDose (SA) Main Business
Table 195. DawaDose (SA) Latest Developments
Table 196. Dawaai (PK) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 197. Dawaai (PK) Third-party Pharmaceutical B2B Platform Product Offered
Table 198. Dawaai (PK) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 199. Dawaai (PK) Main Business
Table 200. Dawaai (PK) Latest Developments
Table 201. PharmaHopers (IN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 202. PharmaHopers (IN) Third-party Pharmaceutical B2B Platform Product Offered
Table 203. PharmaHopers (IN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 204. PharmaHopers (IN) Main Business
Table 205. PharmaHopers (IN) Latest Developments
Table 206. MedPro (IN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 207. MedPro (IN) Third-party Pharmaceutical B2B Platform Product Offered
Table 208. MedPro (IN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 209. MedPro (IN) Main Business
Table 210. MedPro (IN) Latest Developments
Table 211. PharmaSource D2R (IN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 212. PharmaSource D2R (IN) Third-party Pharmaceutical B2B Platform Product Offered
Table 213. PharmaSource D2R (IN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 214. PharmaSource D2R (IN) Main Business
Table 215. PharmaSource D2R (IN) Latest Developments
Table 216. Biddano (IN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 217. Biddano (IN) Third-party Pharmaceutical B2B Platform Product Offered
Table 218. Biddano (IN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 219. Biddano (IN) Main Business
Table 220. Biddano (IN) Latest Developments
Table 221. Pharmint (IN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 222. Pharmint (IN) Third-party Pharmaceutical B2B Platform Product Offered
Table 223. Pharmint (IN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 224. Pharmint (IN) Main Business
Table 225. Pharmint (IN) Latest Developments
Table 226. HealthCRAD Wholesale (IN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 227. HealthCRAD Wholesale (IN) Third-party Pharmaceutical B2B Platform Product Offered
Table 228. HealthCRAD Wholesale (IN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 229. HealthCRAD Wholesale (IN) Main Business
Table 230. HealthCRAD Wholesale (IN) Latest Developments
Table 231. TradeIndia (IN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 232. TradeIndia (IN) Third-party Pharmaceutical B2B Platform Product Offered
Table 233. TradeIndia (IN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 234. TradeIndia (IN) Main Business
Table 235. TradeIndia (IN) Latest Developments
Table 236. ChemDmart (IN) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 237. ChemDmart (IN) Third-party Pharmaceutical B2B Platform Product Offered
Table 238. ChemDmart (IN) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 239. ChemDmart (IN) Main Business
Table 240. ChemDmart (IN) Latest Developments
Table 241. ConectNext (MX) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 242. ConectNext (MX) Third-party Pharmaceutical B2B Platform Product Offered
Table 243. ConectNext (MX) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 244. ConectNext (MX) Main Business
Table 245. ConectNext (MX) Latest Developments
Table 246. Yaydoo (MX) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 247. Yaydoo (MX) Third-party Pharmaceutical B2B Platform Product Offered
Table 248. Yaydoo (MX) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 249. Yaydoo (MX) Main Business
Table 250. Yaydoo (MX) Latest Developments
Table 251. MercadoLibre (B2B Pharma) (AR) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 252. MercadoLibre (B2B Pharma) (AR) Third-party Pharmaceutical B2B Platform Product Offered
Table 253. MercadoLibre (B2B Pharma) (AR) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 254. MercadoLibre (B2B Pharma) (AR) Main Business
Table 255. MercadoLibre (B2B Pharma) (AR) Latest Developments
Table 256. Yeatrade (CO) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 257. Yeatrade (CO) Third-party Pharmaceutical B2B Platform Product Offered
Table 258. Yeatrade (CO) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 259. Yeatrade (CO) Main Business
Table 260. Yeatrade (CO) Latest Developments
Table 261. Axmed (CH) Details, Company Type, Third-party Pharmaceutical B2B Platform Area Served and Its Competitors
Table 262. Axmed (CH) Third-party Pharmaceutical B2B Platform Product Offered
Table 263. Axmed (CH) Third-party Pharmaceutical B2B Platform Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 264. Axmed (CH) Main Business
Table 265. Axmed (CH) Latest Developments


List of Figures
Figure 1. Third-party Pharmaceutical B2B Platform Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Third-party Pharmaceutical B2B Platform Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Third-party Pharmaceutical B2B Platform Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Third-party Pharmaceutical B2B Platform Sales Market Share by Country/Region (2025)
Figure 8. Third-party Pharmaceutical B2B Platform Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Type in 2025
Figure 10. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Product Category in 2025
Figure 11. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Module in 2025
Figure 12. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Core Revenue in 2025
Figure 13. Third-party Pharmaceutical B2B Platform in Retail pharmacies
Figure 14. Global Third-party Pharmaceutical B2B Platform Market: Retail pharmacies (2021-2026) & ($ millions)
Figure 15. Third-party Pharmaceutical B2B Platform in Hospitals & clinics
Figure 16. Global Third-party Pharmaceutical B2B Platform Market: Hospitals & clinics (2021-2026) & ($ millions)
Figure 17. Third-party Pharmaceutical B2B Platform in Pharmaceutical manufacturers
Figure 18. Global Third-party Pharmaceutical B2B Platform Market: Pharmaceutical manufacturers (2021-2026) & ($ millions)
Figure 19. Third-party Pharmaceutical B2B Platform in Wholesalers & distributors
Figure 20. Global Third-party Pharmaceutical B2B Platform Market: Wholesalers & distributors (2021-2026) & ($ millions)
Figure 21. Third-party Pharmaceutical B2B Platform in Primary care & community clinics
Figure 22. Global Third-party Pharmaceutical B2B Platform Market: Primary care & community clinics (2021-2026) & ($ millions)
Figure 23. Third-party Pharmaceutical B2B Platform in Others
Figure 24. Global Third-party Pharmaceutical B2B Platform Market: Others (2021-2026) & ($ millions)
Figure 25. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Application in 2025
Figure 26. Global Third-party Pharmaceutical B2B Platform Revenue Market Share by Player in 2025
Figure 27. Global Third-party Pharmaceutical B2B Platform Market Size Market Share by Region (2021-2026)
Figure 28. Americas Third-party Pharmaceutical B2B Platform Market Size 2021-2026 ($ millions)
Figure 29. APAC Third-party Pharmaceutical B2B Platform Market Size 2021-2026 ($ millions)
Figure 30. Europe Third-party Pharmaceutical B2B Platform Market Size 2021-2026 ($ millions)
Figure 31. Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size 2021-2026 ($ millions)
Figure 32. Americas Third-party Pharmaceutical B2B Platform Value Market Share by Country in 2025
Figure 33. United States Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 34. Canada Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 35. Mexico Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 36. Brazil Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 37. APAC Third-party Pharmaceutical B2B Platform Market Size Market Share by Region in 2025
Figure 38. APAC Third-party Pharmaceutical B2B Platform Market Size Market Share by Type (2021-2026)
Figure 39. APAC Third-party Pharmaceutical B2B Platform Market Size Market Share by Application (2021-2026)
Figure 40. China Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 41. Japan Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 42. South Korea Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 43. Southeast Asia Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 44. India Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 45. Australia Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 46. Europe Third-party Pharmaceutical B2B Platform Market Size Market Share by Country in 2025
Figure 47. Europe Third-party Pharmaceutical B2B Platform Market Size Market Share by Type (2021-2026)
Figure 48. Europe Third-party Pharmaceutical B2B Platform Market Size Market Share by Application (2021-2026)
Figure 49. Germany Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 50. France Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 51. UK Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 52. Italy Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 53. Russia Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 54. Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size Market Share by Region (2021-2026)
Figure 55. Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size Market Share by Type (2021-2026)
Figure 56. Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size Market Share by Application (2021-2026)
Figure 57. Egypt Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 58. South Africa Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 59. Israel Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 60. Turkey Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 61. GCC Countries Third-party Pharmaceutical B2B Platform Market Size Growth 2021-2026 ($ millions)
Figure 62. Americas Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 63. APAC Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 64. Europe Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 65. Middle East & Africa Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 66. United States Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 67. Canada Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 68. Mexico Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 69. Brazil Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 70. China Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 71. Japan Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 72. Korea Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 73. Southeast Asia Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 74. India Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 75. Australia Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 76. Germany Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 77. France Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 78. UK Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 79. Italy Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 80. Russia Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 81. Egypt Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 82. South Africa Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 83. Israel Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 84. Turkey Third-party Pharmaceutical B2B Platform Market Size 2027-2032 ($ millions)
Figure 85. Global Third-party Pharmaceutical B